Response: Diabetic Retinopathy and Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2013;37:262-9)

Jae-Seung Yun; Yu-Bae Ahn
October 2013
Diabetes & Metabolism Journal;Oct2013, Vol. 37 Issue 5, p393
Academic Journal
A response from the authors of the article "Diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus" in the 2013 issue is presented.


Related Articles

  • Erratum: Diabetic Retinopathy and Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus.  // Diabetes & Metabolism Journal;Dec2013, Vol. 37 Issue 6, p488 

    A correction to the article "Erratum: Diabetic Retinopathy and Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus" that was published in the 2013;37 issue is presented.

  • Progression of retinopathy in insulin-treated type 2 diabetic patients. Henricsson, Marianne; Berntorp, Kerstin; Sundkvist, Goran; Fernlund, Per; Sundkvist, Göran // Diabetes Care;Feb2002, Vol. 25 Issue 2, p381 

    Objective: To study the progression of retinopathy 3 years after initiation of insulin therapy.Research Design and Methods: In a prospective, observational case-control study, 42 type 2 diabetic patients were examined at baseline and 1, 3, 6, 12, 24, and 36 months after...

  • Retinopathy in `new' diabetics is more common than we thought.  // Modern Medicine;Aug94, Vol. 62 Issue 8, p27 

    Reports on the incidence of retinopathy in patients with newly diagnosed noninsulin-dependent diabetes in Great Britain. Recommended eye examination of diabetics; Ophthalmologic findings in newly diagnosed type II diabetics.

  • Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study. Chan-Hee Jung; Sang-Hee Jung; Bo-Yeon Kim; Chul-Hee Kim; Sung-Koo Kang; Ji-Oh Mok // Cardiovascular Diabetology;10/14/2015, Vol. 14 Issue 1, p1 

    Background: Whereas a few studies have reported associations of serum omentin levels with subclinical atherosclerosis in patients with diabetes, little information is available with respect to the associations of serum omentin levels and diabetic microvascular complications. The aim of this...

  • Diabetes: Monitoring and counseling patients with prediabetes and type 2 diabetes. Dang, Devra K. // Drug Topics;Nov2011, Vol. 155 Issue 11, p51 

    Approximately 26 million Americans are currently diagnosed with diabetes, and another 79 million have been diagnosed with pre-diabetes, at a total cost to the economy of more than $175 billion per year. The prevalence of type 2 diabetes has been rising in parallel with the rates of obesity, and...

  • Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes.  // New England Journal of Medicine;12/20/2012, Vol. 367 Issue 25, p2458 

    A correction to the article "Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes" that was published in a 2012 issue of "The New England Journal of Medicine" is presented.

  • Diabetic Retinopathy. Brown, Jonathan Betz; Pedula, Kathryn L.; Summers, Kent H. // Diabetes Care;Sep2003, Vol. 26 Issue 9, p2637 

    OBJECTIVE — To measure the extent to which modem intensified risk factor control has lessened the duration-specific prevalence of diabetic retinopathy and, therefore, has decreased the risk of blindness in Americans with type 2 diabetes. RESEARCH DESIGN AND METHODS — Intensified...

  • Relationship between Type 2 Diabetic Retinopathy and Periodontal Disease in Iranian Adults. Amiri, Ahmad Ahmadzadeh; Maboudi, Avideh; Bahar, Adele; Farokhfar, Asadollah; Daneshvar, Fatemeh; Khoshgoeian, Hamid Reza; Nasohi, Mehdi; Khalilian, Alireza // North American Journal of Medical Sciences;Mar2014, Vol. 6 Issue 3, p139 

    Background: Periodontal disease in diabetic patients can compromise a patient's ability to maintain a proper metabolic control and may be associated with diabetic complication. Aims: This study was designed to evaluate the frequency of periodontal disease in patients with type 2 diabetes...

  • Calcium dobesilate did not reduce risk for clinically significant macular edema. Haigh, Christen; Kalvaitis, Katie; Raible, Eric; Southall, Jennifer // Endocrine Today;May2009, Vol. 7 Issue 7, p16 

    The article reports on the findings from the CALDIRET study which showed that type 2 diabetes and mild-to-moderate nonproliferative diabetic retinopathy patients assigned to calcium dobesilate were more likely to have significant macular edema.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics